FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313893304> ?p ?o ?g. }

• W4313893304 endingPage "152" @default.
• W4313893304 startingPage "136" @default.
• W4313893304 abstract "It is unclear whether elevated low-density lipoprotein (LDL) triglycerides are associated with an increased risk of atherosclerotic cardiovascular disease (ASCVD). This study tested the hypothesis that elevated LDL triglycerides are associated with an increased risk of ASCVD and of each ASCVD component individually. The study investigators used the Copenhagen General Population Study, which measured LDL triglycerides in 38,081 individuals with a direct automated assay (direct LDL triglycerides) and in another 30,208 individuals with nuclear magnetic resonance (NMR) spectroscopy (NMR LDL triglycerides). Meta-analyses aggregated the present findings with previously reported results. During a median follow-up of 3.0 and 9.2 years, respectively, 872 and 5,766 individuals in the 2 cohorts received a diagnosis of ASCVD. Per 0.1 mmol/L (9 mg/dL) higher direct LDL triglycerides, HRs were 1.26 (95% CI: 1.17-1.35) for ASCVD, 1.27 (95% CI: 1.16-1.39) for ischemic heart disease, 1.28 (95% CI: 1.11-1.48) for myocardial infarction, 1.22 (95% CI: 1.08-1.38) for ischemic stroke, and 1.38 (95% CI: 1.21-1.58) for peripheral artery disease. Corresponding HRs for NMR LDL triglycerides were 1.26 (95% CI: 1.20-1.33), 1.33 (95% CI: 1.25-1.41), 1.41 (95% CI: 1.31-1.52), 1.13 (95% CI: 1.05-1.23), and 1.26 (95% CI: 1.10-1.43), respectively. The foregoing results were not entirely statistically explained by apolipoprotein B levels. In meta-analyses for the highest quartile vs the lowest quartile of LDL triglycerides, random-effects risk ratios were 1.50 (95% CI: 1.35-1.66) for ASCVD (4 studies; 71,526 individuals; 8,576 events), 1.62 (95% CI: 1.37-1.93) for ischemic heart disease (6 studies; 107,538 individuals; 9,734 events), 1.30 (95% CI: 1.13-1.49) for ischemic stroke (4 studies; 78,026 individuals; 4,273 events), and 1.53 (95% CI: 1.29-1.81) for peripheral artery disease (4 studies; 107,511 individuals; 1,848 events). Elevated LDL triglycerides were robustly associated with an increased risk of ASCVD and of each ASCVD component individually in 2 prospective cohort studies and in meta-analyses of previous and present studies combined." @default.
• W4313893304 created "2023-01-10" @default.
• W4313893304 creator A5002199943 @default.
• W4313893304 creator A5012798335 @default.
• W4313893304 creator A5016803860 @default.
• W4313893304 creator A5056129784 @default.
• W4313893304 creator A5076124471 @default.
• W4313893304 creator A5079373708 @default.
• W4313893304 creator A5079728437 @default.
• W4313893304 date "2023-01-01" @default.
• W4313893304 modified "2023-10-18" @default.
• W4313893304 title "Elevated LDL Triglycerides and Atherosclerotic Risk" @default.
• W4313893304 cites W2020249340 @default.
• W4313893304 cites W2020915011 @default.
• W4313893304 cites W2025001402 @default.
• W4313893304 cites W2036747551 @default.
• W4313893304 cites W2040770080 @default.
• W4313893304 cites W2043092726 @default.
• W4313893304 cites W2066187800 @default.
• W4313893304 cites W2068509302 @default.
• W4313893304 cites W2102011776 @default.
• W4313893304 cites W2102420102 @default.
• W4313893304 cites W2102924526 @default.
• W4313893304 cites W2108169164 @default.
• W4313893304 cites W2114989554 @default.
• W4313893304 cites W2140694890 @default.
• W4313893304 cites W2144516660 @default.
• W4313893304 cites W2147108549 @default.
• W4313893304 cites W2147882394 @default.
• W4313893304 cites W2155822995 @default.
• W4313893304 cites W2169582126 @default.
• W4313893304 cites W2286999219 @default.
• W4313893304 cites W2587991149 @default.
• W4313893304 cites W2775150242 @default.
• W4313893304 cites W2780311549 @default.
• W4313893304 cites W2787647639 @default.
• W4313893304 cites W2810110250 @default.
• W4313893304 cites W2810548862 @default.
• W4313893304 cites W2907939246 @default.
• W4313893304 cites W3018388847 @default.
• W4313893304 cites W3122323559 @default.
• W4313893304 cites W3129818723 @default.
• W4313893304 cites W3164520370 @default.
• W4313893304 cites W3197326839 @default.
• W4313893304 cites W4281628681 @default.
• W4313893304 cites W4282545866 @default.
• W4313893304 doi "https://doi.org/10.1016/j.jacc.2022.10.019" @default.
• W4313893304 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36631208" @default.
• W4313893304 hasPublicationYear "2023" @default.
• W4313893304 type Work @default.
• W4313893304 citedByCount "13" @default.
• W4313893304 countsByYear W43138933042023 @default.
• W4313893304 crossrefType "journal-article" @default.
• W4313893304 hasAuthorship W4313893304A5002199943 @default.
• W4313893304 hasAuthorship W4313893304A5012798335 @default.
• W4313893304 hasAuthorship W4313893304A5016803860 @default.
• W4313893304 hasAuthorship W4313893304A5056129784 @default.
• W4313893304 hasAuthorship W4313893304A5076124471 @default.
• W4313893304 hasAuthorship W4313893304A5079373708 @default.
• W4313893304 hasAuthorship W4313893304A5079728437 @default.
• W4313893304 hasConcept C126322002 @default.
• W4313893304 hasConcept C134018914 @default.
• W4313893304 hasConcept C164705383 @default.
• W4313893304 hasConcept C2778163477 @default.
• W4313893304 hasConcept C2778213512 @default.
• W4313893304 hasConcept C2779134260 @default.
• W4313893304 hasConcept C2780072125 @default.
• W4313893304 hasConcept C2908647359 @default.
• W4313893304 hasConcept C2909478654 @default.
• W4313893304 hasConcept C500558357 @default.
• W4313893304 hasConcept C62746215 @default.
• W4313893304 hasConcept C71924100 @default.
• W4313893304 hasConcept C90924648 @default.
• W4313893304 hasConcept C99454951 @default.
• W4313893304 hasConceptScore W4313893304C126322002 @default.
• W4313893304 hasConceptScore W4313893304C134018914 @default.
• W4313893304 hasConceptScore W4313893304C164705383 @default.
• W4313893304 hasConceptScore W4313893304C2778163477 @default.
• W4313893304 hasConceptScore W4313893304C2778213512 @default.
• W4313893304 hasConceptScore W4313893304C2779134260 @default.
• W4313893304 hasConceptScore W4313893304C2780072125 @default.
• W4313893304 hasConceptScore W4313893304C2908647359 @default.
• W4313893304 hasConceptScore W4313893304C2909478654 @default.
• W4313893304 hasConceptScore W4313893304C500558357 @default.
• W4313893304 hasConceptScore W4313893304C62746215 @default.
• W4313893304 hasConceptScore W4313893304C71924100 @default.
• W4313893304 hasConceptScore W4313893304C90924648 @default.
• W4313893304 hasConceptScore W4313893304C99454951 @default.
• W4313893304 hasIssue "2" @default.
• W4313893304 hasLocation W43138933041 @default.
• W4313893304 hasLocation W43138933042 @default.
• W4313893304 hasOpenAccess W4313893304 @default.
• W4313893304 hasPrimaryLocation W43138933041 @default.
• W4313893304 hasRelatedWork W123759218 @default.
• W4313893304 hasRelatedWork W1980266135 @default.
• W4313893304 hasRelatedWork W2017524567 @default.
• W4313893304 hasRelatedWork W2074076855 @default.
• W4313893304 hasRelatedWork W2084628138 @default.

• next